Allergan confirmed late last week that it would call the shareholder meeting demanded by unsolicited buyers Valeant Pharmaceuticals and activist investor William Ackman.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Au9zH1
Cap comentari:
Publica un comentari a l'entrada